Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1

  • Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, Yukio Osaki, Kazuhide Yamamoto, Michio Sata, Hiroki Ishikawa, Tomoko Ueki, Wenhua Hu, Fiona McPhee, Eric A Hughes, Hiromitsu Kumada
  • Antiviral Therapy, January 2014, International Medical Press
  • DOI: 10.3851/imp2731

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.3851/imp2731

The following have contributed to this page: Eric Hughes